Laboratory Assessment of Possible Myocardial Infarction
Cardiac troponin (I or T) is the preferred biomarker for diagnosing MI, measured at presentation and repeated 3-6 hours later, with an elevated value above the 99th percentile of normal reference range (plus a rising/falling pattern) establishing the diagnosis when coupled with clinical suspicion. 1
Primary Biomarker Testing Protocol
Cardiac Troponin Measurement
- Draw initial troponin at first assessment, then repeat at 3-6 hours after presentation 1
- An additional sample at 12-24 hours may be needed if earlier measurements are negative but clinical suspicion remains high 2
- Diagnostic threshold: Any value exceeding the 99th percentile of the upper reference limit (URL) for the specific assay used 2, 1
- Rising and/or falling pattern is essential to distinguish acute MI from chronically elevated troponin (e.g., in renal failure patients) 2, 1
- Troponin values remain elevated for 7-14 days following MI onset 2
Assay Quality Requirements
- Optimal precision should be coefficient of variation (CV) ≤10% at the 99th percentile 2, 1
- Assays with CV >20% should not be used 1
- Sex-specific values should be employed 2, 1
Alternative Biomarker: CK-MB
If troponin assays are unavailable, use CK-MB measured by mass assay as the best alternative 2
- Measure at initial assessment and 6-9 hours later 2
- Diagnostic threshold: >99th percentile URL with gender-specific values 2
- Requires demonstration of rise and/or fall pattern 2
- Total CK is NOT recommended due to lack of specificity from skeletal muscle distribution 2
Critical Interpretation Considerations
Non-Ischemic Causes of Troponin Elevation
Elevated troponin does not always indicate MI—multiple conditions cause cardiac injury without acute coronary syndrome 2, 3:
- Cardiac: Heart failure (acute/chronic), myocarditis, pericarditis, cardiomyopathy, aortic dissection, contusion 2
- Arrhythmias: Tachy- or bradyarrhythmias 2
- Systemic: Renal failure, pulmonary embolism, sepsis, burns >30% body surface area 2
- Neurologic: Stroke, subarachnoid hemorrhage 2
- Other: Rhabdomyolysis, drug toxicity, extreme exertion 2
Clinical Context is Mandatory
- A single elevated troponin value requires clinical correlation with ischemic symptoms and ECG findings 1
- Careful history is essential when troponin is borderline elevated to avoid inappropriate use of potent antithrombotic agents that cause bleeding 3
- If presentation is not consistent with acute ischemic heart disease, search for alternative causes of cardiac injury 3
Diagnostic Algorithm Integration
Timing Considerations
- Peak troponin at ≥6 hours after symptom onset provides optimal diagnostic accuracy 4, 5
- A normal troponin on initial presentation (especially within 6 hours of chest pain onset) does NOT exclude MI—serial testing is mandatory 2, 3
- For patients presenting >24 hours after symptom onset, the rising/falling pattern is not absolutely required 2
High-Sensitivity Troponin
- Undetectable high-sensitivity troponin T (<5 ng/L) combined with non-ischemic ECG has 99.8% negative predictive value for MI within 30 days 6
- These patients can be safely discharged directly from the emergency department 6
Detecting Reinfarction
For suspected recurrent MI after initial infarction 2:
- Obtain immediate measurement of cardiac marker
- Draw second sample 3-6 hours later
- Reinfarction diagnosed if ≥20% increase in the second sample value 2
- Both troponin and CK-MB provide similar information for this purpose 2
Common Pitfalls to Avoid
- Do not rely on traditional CAD risk factors (hypertension, hypercholesterolemia, smoking) to determine whether to admit or treat for ACS—they are only weakly predictive of acute ischemia 7
- Point-of-care troponin devices may be less sensitive than central laboratory analyzers, potentially missing patients with minor elevations 3
- Central laboratory turnaround time should not exceed 1 hour 3
- Any detectable troponin elevation identifies high-risk patients, with risk increasing proportionally with absolute level 3